Generic name:etanercept-ykro (subcutaneous route) [ ee-TAN-er-sept-- ykro ]
Drug classes:Antirheumatics, TNF alfa inhibitors
Medically reviewed by Drugs.com. Last updated on May 20, 2022.
Serious InfectionsIncreased risk of serious infections leading to hospitalization or death, including tuberculosis (TB), bacterial sepsis, invasive fungal infections (such as histoplasmosis), and infections due to other opportunistic pathogens.Etanercept-ykro should be discontinued if a patient develops a serious infection or sepsis during treatment.Perform test for latent TB; if positive, start treatment for TB prior to starting etanercept-ykro.Monitor all patients for active TB during treatment, even if initial latent TB test is negative.MalignanciesLymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers, including etanercept products .
Commonly used brand name(s)
In the U.S.
- Eticovo
Pharmacologic Class: Etanercept
Uses for Eticovo
Etanercept-ykro injection is used alone or together with other medicines (eg, methotrexate) to reduce signs and symptoms of active arthritis, rheumatoid arthritis, or psoriatic arthritis, such as joint swelling, pain, tiredness, and duration of morning stiffness. This medicine may also slow the progression of damage to the body from active arthritis or rheumatoid arthritis. It may also be used to treat a condition known as ankylosing spondylitis.
Etanercept-ykro is also used in children 2 years of age and older for juvenile idiopathic arthritis. It is also used to treat moderate to severe plaque psoriasis in patients 4 years of age and older who may benefit from receiving phototherapy (ultraviolet light treatment) or other treatments.
This medicine is available only with your doctor's prescription.
Before using Eticovo
In deciding to use a medicine, the risks of taking the medicine must..
